Linagliptin inhibits the growth of human glioblastoma cells
Journal Title: International Neuroscience Conference (NEURO-2023) - Year 2023, Vol 4, Issue 1
Abstract
Glioblastoma is among the most aggressive brain tumors. The prominent features of this tumor include aberrant cell proliferation, a high probability of recurrence, immunosuppression, severe angiogenesis, and infiltrative behavior. Proteases of the cell surface or extracellular matrix (ECM) can contribute to these features by mediating the breakdown of ECM components, regulating the activity of paracrine agents, liberating growth factors of ECM, and shedding cell surface proteins. The dipeptidyl peptidase-4 (DPP-4), a multifunctional membrane-bound protease, is associated with the development and progression of several cancers including glioma. High expression of DPP-4 predicts poor prognosis in glioma patients. Nevertheless, the effects of DPP-4 inhibitors on glioblastoma remain largely unknown. In the present study, we evaluated the effects of linagliptin (a DPP-4 inhibitor) on U87 human glioblastoma cells and compared its effects with temozolomide. It could reduce the survival, proliferation, and migration ability of the glioblastoma cells and increase the intracellular level of reactive oxygen species in a time- and concentration-dependent manner. If clinical trials confirm the results of our study, DPP-4 inhibitors such as linagliptin can be used as add-on therapy with other medications (temozolomide) against brain tumors.
Authors and Affiliations
Ahmad Ghorbani, Roghayeh Rashidi, Shahrzad Anghozeh Yazdi
Keywords
Related Articles
- EP ID EP747389
- DOI -
- Views 2
- Downloads 0
Association between systemic immune-inflammation index and disability among Polish ischemic stroke patients receiving intravenous thrombolysis: a single-center, prospective cohort study
The inflammatory response plays a central role in the pathophysiology of ischemic stroke. One of the newest laboratory markers with potential for predicting the outcomes of ischemic stroke patients is the systemic immune...
Linagliptin inhibits the growth of human glioblastoma cells
Glioblastoma is among the most aggressive brain tumors. The prominent features of this tumor include aberrant cell proliferation, a high probability of recurrence, immunosuppression, severe angiogenesis, and infiltrative...
The effect of GLP-1 agonist (Liraglutide) on the neurological scores, Blood –brain barrier, brain water content and vestibulomotor function after severe traumatic brain injury in male rat: the role of IL-1β and IL-10
Introduction: Liraglutide is a long-acting analogue of Glucagon-like peptide-1 (GLP-1) that is primarily used in type 2 diabetes and obesity. It stimulates GLP-1 receptors and insulin secretion, and is dose-dependent and...
The 4th Annual Meeting of International Center for Neuroscience Research
It is our pleasure to welcome you to International Neuroscience Conference (NEURO-2023). The NEURO-2023 Conference with the slogan “New Gateway to Neuroscience World” will be held on 20-22 October 2023 in conjunction wit...
The effect of intracerebroventricular injection of ghrelin receptor antagonist on the extinction and reinstatement phases following morphine induce conditioning place preference in male rat: a behavioral and biochemical study
Introduction: This increases the release of dopamine in the nucleus accumbens, which determines the sensation of pleasure. The ghrelin receptor is located in many areas of the brain associated with pleasure, reward, and...